PMID: 11916146Mar 28, 2002Paper

Enantioselectivity of some 1-[(benzofuran-2-yl) phenylmethyl] imidazoles as aromatase (P450AROM) inhibitors

Journal of Enzyme Inhibition
G A KhodarahmiP J Nicholls

Abstract

The enantioselectivity ratio ((+)-:(-)-forms) of three substituted 1-[(benzofuran-2-yl) phenylmethyl] imidazoles as inhibitors of aromatase (P450AROM) was 2.16, 12.3 and 1.0 for the 4-methyl-, 4-fluoro- and 4-chloro-substituted compounds, respectively. The (+/-)-compounds were all >1000 times more potent than (+/-)-aminoglutethimide (IC50 = 12 x 10(3) nM). High potency (5.3-65.0 nM) for all the enantiomers studied is unusual since activity usually resides in one form for chiral inhibitors of P450AROM. The 4-methyl derivative was fitted into the model [Furet, P., Batzl, C., Bhatnager, A.S., Francotte, E., Rihs, G. and Lang, M. (1993) J. Med. Chem. 36, pp. 1393-1400] for binding of S-(-)-fadrazole to the active site and the (R)- and (S)- forms both gave a good fitting pattern with (S)-(-)-fadrazole so accounting for their close activity. Docking of both forms into the active site model for P450AROM [Laughton, C.A., Zvelebil, M.J.J.M. and Neidel, S. (1993) J. Steroid Biochem. Mol. Biol. 44, pp. 399-407], using the orientation of (S)-(-)-fadrazole, gave similar strong binding along the position of the C and D rings of the steroid substrate and in the hydrophobic cavity below the A/B rings. The site was probed for group size accommo...Continue Reading

References

Jul 1, 1979·Endocrinology·P E Graves, H A Salhanick
Apr 1, 1991·Biochemical Society Transactions·B Kaye
Jan 1, 1991·Journal of the American Geriatrics Society·R A Pearlman
Sep 1, 1989·Molecular Endocrinology·D PomponS Chen
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C J CorbinE R Simpson
Oct 31, 1988·Biochemical and Biophysical Research Communications·N Harada
Jun 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·L M KoymansH Vanden Bossche
Feb 1, 1995·Nature Structural Biology·J R Cupp-Vickery, T L Poulos
Mar 4, 1994·Journal of Molecular Biology·C A HasemannJ Deisenhofer
Mar 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·C A LaughtonS Neidle
Mar 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·R WhomsleyV Pestellini
Jan 7, 1999·The Journal of Pharmacy and Pharmacology·G A KhodarahmiM Ahmadi

❮ Previous
Next ❯

Citations

Mar 5, 2016·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Ghadamali KhodarahmiElham Khodarahmi
Jun 23, 2005·Journal of Enzyme Inhibition and Medicinal Chemistry·Mohammed R SaberiClaire Simons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.